Back to search

Article

Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in Thais

2023-05-18

Abstract excerpt

<h4>Background: </h4> The prevalence of anti-platelet factor 4 (PF4)/polyanionic antibodies occurring after vaccination with ChAdOx1 nCoV-19 is low. Most of these antibodies are not associated with vaccine-induced thrombotic thrombocytopenia. It remains unknown whether these antibodies are preexisting or occur as a result of vaccination. In this study, we demonstrated the incidence of anti-PF4/polyanionic antibodi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
948a18d0-1154-59b3-bec7-1241587c3c8f
DOI
10.21203/rs.3.rs-2925482/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Incidence of anti-platelet factor4/polyanionic antibodies, thrombocytopenia, and thrombosis after COVID-19 vaccination with ChAdOx1 nCoV-19 in ThaisDOI 10.21203/rs.3.rs-2925482/v1
Thrombosis of Transverse Cerebral Venous Sinus Secondary to Vaccine ChAdOx1-S (Recombinant) First Report in SouthamericaSemantic proximity
Population-Wide Persistent Hemostatic Changes After Vaccination With ChAdOx1-SSemantic proximity
Effect of a COVID-19-Heterologous Vaccination Schedule on Haemostasis: A Subanalysis of the Phase 2, Multicentre, Randomised, Controlled CombiVacS StudySemantic proximity
Vaccine-induced immune thrombotic thrombocytopenia (VITT) is mediated by a stereotyped clonotypic antibodySemantic proximity
Changes in Thrombosis-Related Parameters After AstraZeneca COVID-19 Vaccination in A Male Volunteer: A Case ReportSemantic proximity
Reverse engineering of a pathogenic antibody reveals the molecular mechanism of vaccine-induced immune thrombotic thrombocytopeniaSemantic proximity
Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccination.Semantic proximity
COVID-19 vaccine-associated cerebral venous thrombosis in GermanySemantic proximity
Thrombosis and thrombocytopenia after vaccination against and infection with SARS-CoV-2: a population-based cohort analysisSemantic proximity
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: incidence between 2017 and 2019 and patient profiles from 25.4 million people in six European countriesSemantic proximity
Humoral and cellular immune response against SARS-CoV-2 variants following heterologous and homologous ChAdOx1 nCoV-19/BNT162b2 vaccinationSemantic proximity
Platelet Factor 4 Antibody Persistence and Long-term Pathogenicity in Vaccine-induced Immune Thrombotic ThrombocytopeniaSemantic proximity
Select a neighboring publication to make it the new centre.